-+ 0.00%
-+ 0.00%
-+ 0.00%

*Verastem: IND Cleared for VS-7375, Oral KRAS G12D Inhibitor; Expect to Initiate Phase 1/2a Study in Mid-2025 >VSTM

Dow Jones·05/13/2025 20:36:00

Please log in to view news